Angitia secures $120m to tackle bone health challenges
Longevity Technology - 12-Dec-2024Biotech firm advances osteoporosis therapies and strengthens leadership with key appointment
Join the club for FREE to access the whole archive and other member benefits.
Biotech firm advances osteoporosis therapies and strengthens leadership with key appointment
Mitochondrial dysfunction is most strongly linked to muscle decline
HSS study finds both technologies highly precise and safe for spinal surgery
A new technique from Penn State leverages cell clusters to revolutionize regenerative medicine
Breakthrough MOTYS moves to phase 3 trials, promising lasting relief for knee osteoarthritis
How exercise and nutrition can help you stay active, independent, and well as you grow older
Even small improvements in strength can have significant health benefits
New technology aims to improve diagnosis speed and accuracy in busy emergency departments
Findings offer hope for future therapies targeting sarcopenia and muscle loss
Safety of rapamycin looks good and lean muscle mass among biomarkers trending towards improvement
75% of participants experienced clinical improvement in both pain and function
Funding will primarily be used to advance therapies focused on muscle growth
But, senolytic therapy may not be a universal solution for age-related bone loss
Initial trials show promising results with improved symptoms and reduced waiting
Findings hint at potential breakthroughs in muscle therapy
Nanosilicates shown to provide safer, more precise tissue regeneration than current methods
Experimental stem cell therapy offers hope for spinal cord injury patients
Research opens doors for future interventions to prevent muscle loss
Phase 1b trial shows RJx-01's ability to improve muscle strength, function, and fatigue resistance
Single dose injection targets root causes, offering long-term relief & improved quality of life
Making small changes to your lifestyle can have a significant impact on health
It improved muscles and slowed down the disease in animals
The potential for human trials starting by 2025 suggests rapid progress
SIRT6 activation may be a potential therapeutic target for osteoarthritis
Offering hope for individuals with significant muscle damage